Bill > SB00257

This bill amends existing general statutes to allow emergency medical technicians (EMTs) to administer intranasal glucagon, similar to how they are currently permitted to administer an opioid antagonist. Intranasal glucagon is a medication used to treat severe hypoglycemia (low blood sugar), typically in patients with diabetes who have become unconscious or unable to consume glucose orally. By expanding the scope of EMTs' permitted treatments, the bill aims to provide emergency medical personnel with another critical tool to rapidly address potentially life-threatening blood sugar emergencies. The proposed change would enable EMTs to quickly intervene and help stabilize patients experiencing dangerous drops in blood sugar levels by delivering glucagon through a nasal spray, potentially preventing serious medical complications or death.

Health and Social Services

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00257&which_year=2025